Pulse Biosciences (PLSE) Research & Development (2015 - 2025)
Pulse Biosciences (PLSE) recorded quarterly Research & Development of $11.4 million in Q3 2025, down 5.75% quarter-over-quarter from $12.1 million in Q2 2025, and up 47.9% on a YoY basis from $7.7 million in Q3 2024.
Pulse Biosciences (PLSE) Research & Development (2015 - 2025) Analysis & Trends
Pulse Biosciences' Research & Development history runs 11 years deep, the most recent figure standing at $11.4 million for Q3 2025.
- In Q3 2025, Research & Development rose 47.9% year-over-year to $11.4 million; the TTM figure through Sep 2025 stood at $44.5 million (up 50.84% YoY), while the FY2024 annual figure was $32.3 million, up 16.33% from the prior year.
- Research & Development was $11.4 million for Q3 2025 at Pulse Biosciences, down from $12.1 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $12.1 million in Q2 2025 to a low of $300000.0 in Q1 2021.
- Historically, Research & Development has averaged $7.1 million across 5 years, with a median of $6.8 million in 2022.
- The sharpest annual moves came in 2021 and 2022: Research & Development slumped 95.15% in 2021, then jumped 2156.33% in 2022.
- A 5-year view of Research & Development shows it stood at $5.7 million in 2021, then dropped by 27.62% to $4.1 million in 2022, then surged by 90.45% to $7.8 million in 2023, then surged by 36.71% to $10.7 million in 2024, then climbed by 6.86% to $11.4 million in 2025.
- The last three Research & Development figures came in at $11.4 million (Q3 2025), $12.1 million (Q2 2025), and $10.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 94.27 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 15.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 189.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 98.66 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 139.00 Mn |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11.39 Mn |
| Jun 30, 2025 | 12.09 Mn |
| Mar 31, 2025 | 10.31 Mn |
| Dec 31, 2024 | 10.66 Mn |
| Sep 30, 2024 | 7.70 Mn |
| Jun 30, 2024 | 7.23 Mn |
| Mar 31, 2024 | 6.74 Mn |
| Dec 31, 2023 | 7.80 Mn |
| Sep 30, 2023 | 7.47 Mn |
| Jun 30, 2023 | 6.70 Mn |
| Mar 31, 2023 | 5.83 Mn |
| Dec 31, 2022 | 4.10 Mn |
| Sep 30, 2022 | 4.52 Mn |
| Jun 30, 2022 | 5.46 Mn |
| Mar 31, 2022 | 6.77 Mn |
| Dec 31, 2021 | 5.66 Mn |
| Sep 30, 2021 | 6.46 Mn |
| Jun 30, 2021 | 7.46 Mn |
| Mar 31, 2021 | 300,000.00 |
| Dec 31, 2020 | 7.43 Mn |